Alexandra Forestier
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Inflammatory Myopathies and Dermatomyositis, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study(2019)104 cited
- → Altered B lymphocyte homeostasis and functions in systemic sclerosis(2018)97 cited
- → Role of B cells in the pathogenesis of systemic sclerosis(2016)57 cited
- → Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database(2020)56 cited
- → Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study(2021)46 cited
- → Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors(2020)32 cited
- No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.(2018)
- → Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology(2018)11 cited
- → Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene(2015)8 cited
- → Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristics(2022)7 cited